DXCM - Dexcom Inc
NYSE * Health Care * Health Care Equipment & Supplies
$73.43
$-0.95 (-1.28%)
About Dexcom Inc
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DXCM Key Statistics
Market Cap
$28.64B
P/E Ratio
35.13
P/B Ratio
10.42
EPS
$2.09
Revenue Growth
+0.1%
Profit Margin
0.2%
Employees
11,000
How DXCM Compares to Peers
P/E Rank
#2
of 2
Margin Rank
#1
of 2
Growth Rank
#2
of 2
Size Rank
#2
of 2
Dexcom Inc Company Information
- Headquarters
- California; U.S.A
- Website
- www.dexcom.com
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies